Assessment of the REPLACE Study Composite Endpoint in the PATENT Study and Association With Long-Term Outcomes in Riociguat-Treated Patients. rev. colomb. neumol. 2020, 31 (2). https://doi.org/10.30789/rcneumologia.v31.n2.2019.451.